MassMutual Private Wealth & Trust FSB Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

MassMutual Private Wealth & Trust FSB decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 37.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,542 shares of the healthcare conglomerate's stock after selling 19,015 shares during the quarter. MassMutual Private Wealth & Trust FSB's holdings in UnitedHealth Group were worth $16,520,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.0%

UNH traded down $0.01 during midday trading on Thursday, hitting $298.11. The company had a trading volume of 16,213,440 shares, compared to its average volume of 6,743,288. The company has a market capitalization of $270.42 billion, a price-to-earnings ratio of 19.23, a PEG ratio of 1.37 and a beta of 0.56. The stock's 50 day moving average price is $435.12 and its 200 day moving average price is $496.39. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter last year, the firm posted $6.91 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. TD Securities restated a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Robert W. Baird decreased their price objective on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Raymond James cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective on the stock. in a report on Monday, May 19th. Finally, Mizuho cut their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now owns 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John H. Noseworthy purchased 300 shares of the company's stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.